COLUMBIA, Md., June 7 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK - News) announced today that it is presenting at the Fifth Annual Needham & Company, LLC Biotechnology and Medical Technology Conference in New York. The conference is being held June 14-15, 2006 at the New York Palace Hotel. Peter L. Buzy, CFO, will be presenting on Wednesday, June 14, at 1:30 p.m. Eastern Time.
A live audio webcast of Martek’s presentation will be available by accessing the following link: http://www.wsw.com/webcast/needham15/matk/http://www.wsw.com/webcast/needham15 /ctrx/http://www.wsw.com/webcast/needham15/phrm/http://www.wsw.com/webcast/nee dham15/avgn/
Martek Biosciences Corporation (Nasdaq: MATK - News) is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces Martek DHA(TM), a vegetarian omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
CONTACT: Kyle Stults, Investor Relations of Martek Biosciences Corporation, +1-410-740-0081.
Source: Martek Biosciences Corporation
